本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii Dissertationsから、本文を自由に閲覧できる場合があります。
Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy.
Available in National Diet Library
Find on the publisher's website
国立国会図書館デジタルコレクション
Digital data available
Search by Bookstore
Read this material in an accessible format.
Table of Contents
2019-01-04 再収集
2019-01-04 再収集
Search by Bookstore
Read in Disability Resources
- Other Services
Bibliographic Record
You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.
- Material Type
- 博士論文
- Author/Editor
- 佐々木, 勇人
- Author Heading
- Publication Date
- 2015-03-23
- Publication Date (W3CDTF)
- 2015-03-23
- Alternative Title
- 胆道癌患者に対するGemcitabineを用いた術後補助化学療法においてhuman equilibrative mucleoside transporter 1およびribonucleotide reductase regulatory subunit M1発現の同時解析は予後の予測価値を高める
- Degree grantor/type
- 広島大学
- Date Granted
- 2015-03-23
- Date Granted (W3CDTF)
- 2015-03-23